Disclosures

  • SeedInvest’s due diligence process is no guarantee of success or future results. All investors should carefully review each investment opportunity and cancel their subscription within the allotted time-frame if they do not feel comfortable making any specific investment based on their own DD. Learn more about due diligence on the SeedInvest Blog (https://www.seedinvest.com/blog/angel-investing/how-to-assess-an-investment) and our vetting process in our FAQs (https://intercom.help/seedinvest/en/).

  • SeedInvest’s selection criteria does not suggest higher quality investment opportunities nor does it imply that investors will generate positive returns in investment opportunities on SeedInvest. Learn more about due diligence on the SeedInvest Blog (https://www.seedinvest.com/blog/angel-investing/how-to-assess-an-investment) and our vetting process in our FAQs (https://intercom.help/seedinvest/en/).

  • Diversification is only across multiple early-stage investment opportunities within the asset class. There is no guarantee that this program will lead to a well-balanced portfolio of companies across industry types or stages across the asset class. In addition, enrolling in this program will not lead to diversification across your entire investment portfolio. In order to achieve diversification, we do not recommend you allocate more than 10% of your entire investment portfolio to alternative assets.

  • Testimonials may not be representative of the experience of others and are no guarantee of future performance or success. No individuals were compensated in exchange for their testimonials.

The Biggest Raise in SeedInvest History: On-Demand Prescription Pharmacy NowRx Crowdfunds $20 Million

 

History was made in June 2020 when NowRx, the technology-driven pharmacy providing free, same-day delivery, raised $20 million in SeedInvest’s largest crowdfunded round to date. This brings NowRx’s total funding to around $30M, giving the company a post-money valuation of $85M. The recent round, in which 9,556 investors participated, marks the third time NowRx has fundraised successfully on SeedInvest, advancing the company’s growth over multiple equity crowdfunded rounds.

CEO Cary Breese notes, “Raising funds under Regulation A has enabled NowRx to raise substantial capital while managing our own tech development and growth strategy without undue influence from large institutional venture funds, which tend to favor growth over quality and consistency due to their own internal timelines. SeedInvest has been a leader in the Regulation A and crowdfunding space since it first emerged as a sound alternative to traditional venture fundraising. By being out in front, SeedInvest has developed the services and community necessary to help companies be successful in their fundraising efforts. SeedInvest has been a fantastic partner for NowRx.”

During the campaign, potential investors exchanged almost 1,000 posts on the SeedInvest discussion forum with NowRx as part of their crowd-sourced due diligence. In addition to providing NowRx with capital, the high levels of investor engagement with their campaign also helped the company increase awareness and expand their footprint.

While many businesses shuttered as the economic repercussions of the pandemic were realized, NowRx flourished, witnessing a record breaking Q1 2020, generating $2.8M–the highest quarterly volume in the company’s history. Cary attributes this uptick both to the company’s cumulative growth and to COVID-19. Many people with underlying health conditions were unsurprisingly looking for a way to avoid visiting a brick-and-mortar pharmacy and risking exposure, a market fit which was not missed by SeedInvest investors.

NowRx CEO Cary Breese explained, “SeedInvest was the perfect choice for our fundraise, especially during this time, because we were able to efficiently communicate with a large number of investors with whom NowRx’s response to COVID-19 really resonated.”

 

This post was written by SeedInvest on September 16, 2020

Raise a Round

A streamlined fundraising process for companies at every stage.

Choose how much you’d like to allocate to startup investing today.